Geoffrey Kozen focuses his practice on antitrust, class action, and other complex commercial litigation. He has experience representing clients, ranging from individuals to large corporations, in a wide array of high-stakes disputes and has prosecuted and defended numerous actions in trial and appellate courts throughout the country. And while Mr. Kozen never backs down from litigation, he also recognizes that litigation is a tool to further a client’s business objectives, and often the best outcome lies in using leveraging litigation into a business resolution.
Mr. Kozen is also dedicated to pro bono work. He has particular interest in representing clients in immigration courts and in advocating for those facing domestic violence.
Prior to joining Robins Kaplan, Geoffrey worked for the United States Senate and for a national antitrust policy organization.
- In re: LIBOR-Based Financial Instruments Antitrust Litigation, 11-md-02262 (S.D.N.Y.) Robins Kaplan represents an investment management company that holds financial instruments with provisions to receive interest payments at rates indexed to British Bankers’ Association London Interbank Offered Rate (“BBA LIBOR”) benchmark rates set by defendant banks. Plaintiffs allege that defendants, who are panel bank members that report Intercontinental Exchange (“ICE”) LIBOR rates daily for the benchmark’s calculation, conspired to suppress those rates between August 2007 through at least 2011. The case is ongoing before the trial court.
- In re: ICE LIBOR-Based Financial Instruments Antitrust Litigation, 19-cv-00439 (S.D.N.Y.) Robins Kaplan serves a co-lead counsel on behalf of a class of plaintiffs who hold financial instruments with provisions to receive interest payments at rates indexed to Intercontinental Exchange London Interbank Offered Rate (“ICE LIBOR”) benchmark rates set by defendant banks. Plaintiffs allege that defendants, who are panel bank members that report ICE LIBOR rates daily for the benchmark’s calculation, conspired to suppress those rates since February 2014.
- In re Cattle Antitrust Litigation, 19-cv-01222 (D. Minn.) Robins Kaplan serves as the court-appointed liaison counsel on behalf of cattle ranchers who sold fed cattle to meatpacking defendants, including Tyson and Cargill, among others. Plaintiffs allege that defendants conspired to suppress the price paid for fed cattle since 2015. The case is ongoing before the trial court.
- In re Payment Card Interchange Fee and Merchant Discount Antitrust Litigation, 05-md-01720 (E.D.N.Y.) Robins Kaplan, serving as plaintiffs’ co-lead counsel, reached a $6.25 billion antitrust settlement on behalf of a class of over 10 million U.S. merchants who have accepted Visa and Mastercard credit cards and debit cards for the purchase of goods and services. This settlement, the result of 15 years of litigation, is the largest known settlement of a private antitrust case in the 120-year history of the Sherman act. The defendants include Visa and Mastercard, as well as major card-issuing banks such as JPMorgan Chase, Bank of America, Citibank, Wells Fargo, and Capital One. The settlement, which is subject to possible reduction of up to $700 million in the event opt-outs exceed a certain threshold, was given final approval by the court in December 2019. Appeals are ongoing.
- In re Wholesale Grocery Products Antitrust Litigation, 09-md-02090 (D. Minn.) Robins Kaplan defended grocery wholesaler Supervalu Inc. in a putative antitrust class action by grocery retailers in 13 states alleging that Supervalu and another wholesaler, C&S Wholesale Grocers, Inc., conspired to allocate territories and customers in the Midwest and New England in violation of the Sherman Act. This significant multidistrict litigation began in 2008 and involved five separate Eighth Circuit appeals and a petition for certiorari to the U.S. Supreme Court. The case was ultimately resolved to the benefit of all parties.
- Robins Kaplan is representing The Gap Inc. and its subsidiaries in suits seeking relief related to hundreds of store leases affected by COVID-19 store closures and the effects of the pandemic across the United States
- Anthem v. Insys, No. 2:17-cv-02286 (D. Ariz.) Robins Kaplan represents insurer Anthem in litigation against the pharmaceutical manufacturer Insys alleging that Insys marketed Subsys, a powerful painkiller indicated only for cancer patients, to patients who did not have cancer and then lied to Anthem to get the prescriptions paid. On June 10, 2019, the filing was stayed due to Insys’s bankruptcy.
- Amara Legal Center, Co-Founder and Volunteer (2014-2015)
The In-House Lawyer’s Field Guide to Antitrust Compliance in the Biden Era
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.